about
PTOV-1, a novel protein overexpressed in prostate cancer, shuttles between the cytoplasm and the nucleus and promotes entry into the S phase of the cell division cycleMembrane androgen binding sites are preferentially expressed in human prostate carcinoma cellsIdentification of androgen-coregulated protein networks from the microsomes of human prostate cancer cellsAdvances in genetics: widening our understanding of prostate cancerTargeting the androgen receptor in prostate and breast cancer: several new agents in developmentIdentification of SRC3/AIB1 as a Preferred Coactivator for Hormone-activated Androgen ReceptorPlexin-B1 mutations in prostate cancer.HE3235 inhibits growth of castration-resistant prostate cancer.Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant.Physical labeling of papillomavirus-infected, immortal, and cancerous cervical epithelial cells reveal surface changes at immortal stageSpatial interactions and cooperation can change the speed of evolution of complex phenotypes.Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcriptionAndrogen receptor functional analyses by high throughput imaging: determination of ligand, cell cycle, and mutation-specific effectsAtorvastatin and celecoxib in combination inhibits the progression of androgen-dependent LNCaP xenograft prostate tumors to androgen independenceERK regulates calpain 2-induced androgen receptor proteolysis in CWR22 relapsed prostate tumor cell linesAndrogen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivo.Systematic structure-function analysis of androgen receptor Leu701 mutants explains the properties of the prostate cancer mutant L701H.Redefining hormone resistance in prostate cancer.The impact of point mutations in the human androgen receptor: classification of mutations on the basis of transcriptional activityGrowth of LAPC4 prostate cancer xenograft tumor is insensitive to 5α-reductase inhibitor dutasteride.CYP17A1 inhibitors in castration-resistant prostate cancerTowards nonspecific detection of malignant cervical cells with fluorescent silica beads.Angiogenin as a molecular target for the treatment of prostate cancer.Androgen receptor gene polymorphisms and alterations in prostate cancer: of humanized mice and men.Complex impacts of PI3K/AKT inhibitors to androgen receptor gene expression in prostate cancer cells.Hormones and prostate carcinogenesis: Androgens and estrogens.A profile of enzalutamide for the treatment of advanced castration resistant prostate cancer.IκBα mediates prostate cancer cell death induced by combinatorial targeting of the androgen receptorUnique bisphenol A transcriptome in prostate cancer: novel effects on ERbeta expression that correspond to androgen receptor mutation status.Genomic and epigenomic alterations in prostate cancer.Increased PrLZ-mediated androgen receptor transactivation promotes prostate cancer growth at castration-resistant stage.Antitumor effects of bladder cancer-specific adenovirus carrying E1A-androgen receptor in bladder cancer.The diverse and contrasting effects of using human prostate cancer cell lines to study androgen receptor roles in prostate cancer.Androgen receptor inactivation contributes to antitumor efficacy of 17{alpha}-hydroxylase/17,20-lyase inhibitor 3beta-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene in prostate cancer.RNA editing of androgen receptor gene transcripts in prostate cancer cells.Profiling human androgen receptor mutations reveals treatment effects in a mouse model of prostate cancerThe role of androgen receptor mutations in prostate cancer progression.Abiraterone acetate: oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer.Critical role of androgen receptor level in prostate cancer cell resistance to new generation antiandrogen enzalutamide.Downregulation of key regulatory proteins in androgen dependent prostate tumor cells by oncolytic reovirus.
P2860
Q24685775-17BA78F0-58E2-41C1-BF72-4E3297029264Q24800710-992A1AA6-7193-4EB5-92C6-863BA72273A4Q24806811-C8D6E622-8694-43C2-B85F-B7D70A9ED626Q26740628-3F05C489-35C5-4CDC-A7DE-6392F31EF92CQ27009424-7E9F89AE-3E5B-472E-A317-35D50DF76F09Q27659041-08865C98-5807-481B-A7DB-A755F20F479EQ30480866-6736AD6C-6772-4C31-81BA-49FAA9AC6436Q30491204-F8A9A0D7-7E0B-492A-B5FE-D16C4273850FQ30495758-D6F9EB6E-A956-45EE-9E0B-063555D56996Q30543116-A53CEA4D-9324-4CCE-8B18-DE5842A0107EQ30585147-DBD58E47-62D1-47F6-82DD-46B7A9A93721Q33292178-40F8D0D1-7B13-4B72-A91C-60FF138EAB22Q33382106-841FB5E6-93A9-4324-8CB5-11B959513860Q33579568-1E8CCCD7-B127-4F5C-ADE3-EEEECB2C2954Q33593873-837B512F-E94F-49A8-B305-1D6384BEFE66Q33607836-98349975-4E5C-4CEF-976E-ED5932D9A413Q33717757-D0BA20C5-71F7-4D3A-AC09-08917B5CE33CQ33903836-02BECAA9-D07C-4525-8F8E-7D11E3B8BC95Q34189517-287B00BB-47F1-405D-81AD-A3AD8066A13AQ34448181-BF498060-5DE3-4B2E-816C-4ABF22548D6DQ34456638-2C44E4CB-47B8-4B1D-9ADE-7F3B9DEC6205Q34493383-189500DD-F1C7-48FA-A91A-778C653D3B11Q35090356-C591A03D-C391-42B1-B10A-3F4EC76B66BDQ35281575-B652B68E-4362-4C0D-94EE-9E6BF73EA137Q35382353-7316D86F-9B17-4A08-B314-2046649A3BF4Q35687198-50F3267C-9704-4020-9667-CC2AEBAAFBACQ35754996-B49770F2-5DB0-40BF-A7E7-ABB967426063Q35933129-DA1DDE0F-AAFE-4234-AB0A-755E03EEB284Q36130890-8C7C77A4-13A6-49E9-B1D9-FE38DAF6AB3AQ36374578-BC967D38-BE1D-4CB3-9444-C91833779762Q36587631-F43D3911-FDDC-4120-97D3-2213036B0A36Q36934025-F1C99C2F-29C1-4011-8117-89113D68CBDDQ37074725-9E870286-D346-40C7-B7EB-B2B7334A3C42Q37098796-6E4E71CF-427E-4AEC-A45E-14E6BE6B0951Q37142544-E5D8BDE3-0BA5-4FBF-8B2F-E3C318D999B4Q37357108-02AD4B4B-F162-4C6D-9F11-74F4B1AA9054Q37590123-C0538017-A10D-4533-A4A4-599A4292A51FQ37980116-527EBADF-6BCD-41E5-887E-2DDBB58BBCAFQ38754074-77D74228-A055-4618-84A1-D57373504E61Q38844346-EB5E53FA-73BF-4E63-8171-0EA58A08E78E
P2860
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Androgen receptor mutations in prostate cancer.
@en
Androgen receptor mutations in prostate cancer.
@nl
type
label
Androgen receptor mutations in prostate cancer.
@en
Androgen receptor mutations in prostate cancer.
@nl
prefLabel
Androgen receptor mutations in prostate cancer.
@en
Androgen receptor mutations in prostate cancer.
@nl
P2093
P1433
P1476
Androgen receptor mutations in prostate cancer
@en
P2093
DiConcini D
Marcelli M
P304
P407
P577
2000-02-01T00:00:00Z